跳至主要内容
临床试验/NCT00916929
NCT00916929已完成不适用

Detect Fluid Early From Intra-thoracic Impedance Monitoring

Abbott Medical Devices67 个研究点 分布在 1 个国家目标入组 162 人开始时间: 2009年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
162
试验地点
67
主要终点
False Positive Rate

研究概览

简要总结

To demonstrate the safety and effectiveness of the Impedance Monitoring Feature in St Jude Medical cardiac devices.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must have a St. Jude Medical (SJM) ICD or CRT-D for at least 31 days
  • Must have had an episode of acute decompensated heart failure (ADHF) within the past 6 months

排除标准

  • History of kidney disease requiring hemodialysis
  • Refractory end stage heart failure

研究组 & 干预措施

Implantable Cardioverter Defibrillator (ICD)

Other

Impedance Monitoring Feature in an Implantable Cardioverter Defibrillator (ICD).

干预措施: Impedance Monitoring Feature (Device)

Cardiac Resynchronization Therapy (CRT-D)

Other

Impedance Monitoring Feature in a Cardiac Resynchronization Therapy (CRT-D) device.

干预措施: Impedance Monitoring Feature (Device)

结局指标

主要结局

False Positive Rate

时间窗: 6-months

False Positive Rate is the the number of departures from the device's programmed threshold that are unrelated to a heart failure event. The False Positive Rate per patient year of follow up should be less than 1.5.

次要结局

  • Sensitivity(6-months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (67)

Loading locations...

相似试验